US FDA completes pre-approval inspection of Lupin’s edaravone oral suspension facility in Somerset with no observations: Our Bureau, Mumbai Monday, February 3, 2025, 14:45 Hrs [ ...

Special Report: Medtech EBR Systems (ASX:EBR) will kick off the new year with a manufacturing pre-approval inspection (PAI) with the US Food and Drug Administration (FDA), which has been scheduled ...

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field ...

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has ...

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop ...

Lupin has announced that the the United States Food and Drug Administration (US FDA) has concluded the pre-approval inspection of the company's Edaravone Oral Suspension, located at its manufacturing ...

On Tuesday, the FDA approved Johnson & Johnson’s (NYSE ... The rejection was related to observations as part of a standard pre-approval inspection at a manufacturing facility.